Mestinon-SR 180 mg (Pyridostigmine Bromide TABLET (EXTENDED-RELEASE)) 180 MG

MESTINON-SR 180 MG is an extended-release tablet containing pyridostigmine bromide, used to manage symptoms of myasthenia gravis. This medication helps improve muscle strength and function.

Strength

180 MG

Pack Size

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MESTINON-SR 180 MG is primarily used to treat myasthenia gravis, a condition that causes weakness in the voluntary muscles. Pyridostigmine bromide works by improving nerve-to-muscle communication, which can help alleviate muscle weakness and fatigue. This medication is often prescribed to manage symptoms and enhance muscle function in individuals with myasthenia gravis.

Side Effects

Common effects of MESTINON-SR 180 MG may include improved muscle strength and reduced fatigue. Some users might experience increased salivation, sweating, or gastrointestinal discomfort. These effects can vary depending on individual responses to the medication.

Precautions & Warnings

MESTINON-SR 180 MG should be handled with care, especially by individuals with certain medical conditions such as asthma, epilepsy, or stomach ulcers. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Keep the tablets out of reach of children and store them as directed.

Avoid Interactions

MESTINON-SR 180 MG may interact with other medications, including anticholinergics, which can reduce its effectiveness. It is also important to be cautious when combining this medication with alcohol or other substances that can affect the nervous system. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

MESTINON-SR 180 MG is used to manage symptoms of myasthenia gravis, a condition that causes muscle weakness and fatigue.

Pyridostigmine bromide improves nerve-to-muscle communication, helping to alleviate muscle weakness and fatigue.

Common side effects may include increased salivation, sweating, and gastrointestinal discomfort.

It is important to consult a healthcare provider before combining MESTINON-SR 180 MG with other medications, as interactions can occur.

MESTINON-SR 180 MG should be stored as directed on the packaging, typically at room temperature and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.